Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Dulera combines mometasone furoate and formoterol fumarate to control inflammation and relax airway muscles in patients 12 years and older with severe persistent asthma, with the typical high-dose regimen being 2 inhalations of the 200 mcg/5 mcg strength twice daily. Physicians use lung function tests, symptom tracking and side effect assessments to tailor dosing and improve respiratory outcomes.
Important factors like inhaler technique, tapering schedules, lifestyle strategies and side effect monitoring can influence your next steps; see complete details below.
Severe persistent asthma requires both powerful anti-inflammatory control and reliable bronchodilation. Dulera combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta₂-agonist (formoterol fumarate). Getting the dulera dosage for severe persistent asthma right can improve lung function, reduce exacerbations, and help you breathe easier.
Dulera is a combination inhaler that delivers:
Together, they target both the underlying inflammation and the bronchospasm that characterize severe persistent asthma.
Dulera is approved for patients aged 12 years and older with asthma not adequately controlled on a low- to medium-dose ICS alone. It's particularly useful when:
When symptoms persist despite other therapies, your doctor may prescribe a higher dulera dosage for severe persistent asthma.
Dulera comes in two strengths:
Dosage is expressed as "inhalations per dose, twice daily." Here's how doctors typically structure it:
| Dosage Strength | Low-Dose Regimen | Medium-Dose Regimen | High-Dose Regimen |
|---|---|---|---|
| 100 / 5 | 1 inhalation twice daily | 2 inhalations once daily or 1 inhalation twice daily | Not commonly used |
| 200 / 5 | Not routinely used | 1 inhalation twice daily | 2 inhalations twice daily (max) |
For severe persistent asthma, the usual high-dose regimen is:
Always start at the lowest effective dose and increase only under medical supervision.
Your doctor will use several key metrics to ensure your dulera dosage for severe persistent asthma is optimized:
Regular follow-up (every 1–3 months initially) helps your doctor adjust dosing and address any concerns.
Proper inhaler technique is crucial. Follow these steps:
While Dulera is generally well tolerated, be aware of:
If you experience severe chest pain, vision changes, or signs of adrenal crisis (e.g., fatigue, dizziness), speak to a doctor immediately.
Once asthma is controlled for at least 3 months—with normal lung function and no exacerbations—your doctor may:
Never stop Dulera abruptly; taper under medical supervision to avoid rebound inflammation.
Medication is just one part of asthma control. Complement Dulera therapy with:
If you're experiencing new or worsening respiratory symptoms, use Ubie's free AI-powered Bronchial Asthma symptom checker to better understand your condition and determine whether you should seek medical attention.
Even with optimal dosing, severe persistent asthma can flare. Call your healthcare provider if you notice:
For any life-threatening signs—severe breathlessness at rest, confusion, or loss of consciousness—seek emergency help right away.
Asthma management is a partnership. By understanding the dulera dosage for severe persistent asthma and staying engaged with your healthcare team, you can achieve the best possible control and quality of life.
(References)
* Hoshino M, Ohtawa J, et al. Mometasone furoate/formoterol fumarate for the treatment of asthma: a review. *Ther Clin Risk Manag*. 2010 Sep 28;6:461-71. doi: 10.2147/TCRM.S10578. PMID: 20957018.
* Nathan RA. Mometasone furoate/formoterol fumarate for the treatment of asthma. *Expert Rev Respir Med*. 2011 Apr;5(2):167-75. doi: 10.1586/ers.11.8. PMID: 21469850.
* Virchow JC, Kuna P, et al. Clinical efficacy of mometasone furoate/formoterol fumarate in patients with moderate-to-severe asthma: a systematic review. *Respir Med*. 2012 Jun;106(6):783-93. doi: 10.1016/j.rmed.2012.02.001. PMID: 22387190.
* Sanford M, McCormack PL. Mometasone furoate/formoterol fumarate: a review of its use in adults and adolescents with asthma. *Drugs*. 2010 Mar 12;70(4):493-519. doi: 10.2165/11204620-000000000-00000. PMID: 20230132.
* Wang T, Su C, et al. Safety and efficacy of mometasone furoate/formoterol fumarate fixed-dose combination in patients with asthma: a systematic review and meta-analysis. *J Asthma Allergy*. 2016 Feb 26;9:19-33. doi: 10.2147/JAA.S100259. PMID: 26973347.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.